SECTION O. MEDICATIONS

Similar documents
Completing the NPA online Patient Safety Incident Report form: 2016

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

Dosage Administration

Herbal Medicines: Traditional Herbal Registration

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009

Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams

Annex III. Amendments to relevant sections of the Product Information

Pain relief after surgery

Appendix 1 Example of Homely Remedy Policy

3903 Fair Ridge Drive, Suite 209, Fairfax, VA Harry Byrd Hwy, Suite 285, Ashburn, VA *How did you hear about our program?

You may have a higher risk of bleeding if you take warfarin sodium tablets and:

FDA Dietary Supplement cgmp

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.

BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE. RHEUMATOLOGY SHARED CARE GUIDELINE for DMARDs

Methadone Maintenance Treatment for Opioid Dependence

Childhood Immunization Status (NQF 0038)

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017

2017 Optum, Inc. All rights reserved BH1124_112017

Benepali (etanercept): Brief training on additional Risk Minimisation Measures

Cancer Association of South Africa (CANSA)

Section J. Health Conditions

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator

2017 PEPFAR Data and Systems Applied Learning Summit Day 2: MER Analytics/Available Visualizations, Clinical Cascade Breakout Session TB/HIV EXERCISE

University College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service

Year 10 Food Technology. Assessment Task 1: Foods for Special Needs. Name: Teacher:

Appendix C Guidelines for treating status epilepticus in adults and children

Corporate Governance Code for Funds: What Will it Mean?

MEDICATION GUIDE. (canagliflozin) Tablets

Original Policy Date 12:2013

School Medication Authorization Form. School Grade Teacher. Emergency Phone No: To be completed by the student's physician: Name of Medication:

Meaningful Use Roadmap Stage Edition Eligible Hospitals

Obesity/Morbid Obesity/BMI

Percutaneous Nephrolithotomy (PCNL)

Section 5. Study Procedures

S.K.J Construction Ltd Groundwork & Civil Engineering

Coronary Artery Disease (CAD): Beta Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) (NQF 0070)

Medication Guide SIGNIFOR [sig-na-for] (pasireotide) Injection

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT

Family Medicine Clinical Pharmacy Forum Vol. 3, Issue 5 (September/October 2007)

Childhood Immunization Status (NQF 0038)

Code of employment practice on infant feeding

National Hospital Inpatient Quality Reporting Measures Specifications Manual Release Notes

RoActemra (tocilizumab) for Giant Cell Arteritis (GCA) subcutaneous (SC) formulation

Generic Immunosuppressants in the Specialist Area of Transplantation Consensus on Implications and Practical Recommendations

A pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps.

PACKAGE LEAFLET: INFORMATION FOR THE USER

US Public Health Service Clinical Practice Guidelines for PrEP

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain

BP Thresholds for Medical Review

Reliability and Validity Plan 2017

National Hospital Inpatient Quality Reporting Measures Specifications Manual Release Notes

ACRIN 6666 Screening Breast US Follow-up Assessment Form

SUMMACARE COMMERCIAL MEDICATION REQUEST GUIDELINES. ANTI-OBESITY AGENTS Generic Brand HICL GCN Exception/Other QSYMIA 32515, 32744, 32746, 32745

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

Colonoscopy MoviPrep Split-dose Prep Guide

Shared Care Protocol for the prescribing and monitoring of maintenance doses of azathioprine in Inflammatory Bowel Disease

Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018

Coding. Training Guide

MEDICATION GUIDE. Reference ID:

My Symptoms and Medical History for Adult Chronic Immune Thrombocytopenia (ITP)

MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion

Medication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII)

MEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP

The Mental Capacity Act 2005; a short guide for the carers and relatives of those who may need support. Ian Burgess MCA Lead 13 February 2017

SECTION 8: MANAGEMENT OF ACUTELY DISTURBED BEHAVIOUR. Formulary and Prescribing Guidelines

Commissioning Policy: South Warwickshire CCG (SWCCG)

EMC believes the information in this publication is accurate as of its publication date. The information is subject to change without notice.

PATIENT INFORMATION. effective for the treatment of the flu in people with long-time (chronic) heart problems or breathing problems.

MEDICATION GUIDE. (Interferon alfa-2b)

2017 CMS Web Interface

Pediatric and adolescent preventive care and HEDIS *

MEDICATION GUIDE REVLIMID (rev-li-mid) (lenalidomide) capsules What is the most important information I should know about REVLIMID?

MEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP

STATISTICAL ANALYSIS PLAN. Addendum 1 (V 1 12SEP2015)

2013 DATA COLLECTION GUIDE Summary Data Submission. Optimal Asthma Care. (07/01/2012 to 06/30/2013 Dates of Service)

LAST UPDATED FEBRUARY 1, Prepared exclusively for UCanQuit2 Chat Team

Colonoscopy Colyte Split-dose Prep Guide

Guidelines for the Admission of Children and Young People with an Eating Disorder

Package leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers

Formulary and Prescribing Guidelines

PART III: CONSUMER INFORMATION

ICD-10-CM Coding Basics Chapter Specifics

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria

STANDARD FOR POMEGRANATE (CODEX STAN )

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE

Swindon Joint Strategic Needs Assessment Bulletin

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers

Triumeq (abacavir, dolutegravir and lamivudine) Product Backgrounder for US Media

Tick fever is a cattle disease caused by any one of the following blood parasites:

Chinese Herbal Formulae CMHB221

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS)

Safety of HPV vaccination: A FIGO STATEMENT

Hyperglycaemia: Management of Preterm Infants in Neonatal Intensive Care

Imaging tests allow the cancer care team to check for cancer and other problems inside the body.

Transcription:

SECTION O. MEDICATIONS 1. NUMBER OF MEDICA TIONS (Recrd the number f different medicatins used in the last 7 days; enter "0" if nne used)

O1. Number f Medicatins (7-day lk back) Intent: Prcess: Cding: T determine the number f different medicatins (ver-the-cunter and prescriptin drugs) the resident has received in the past seven days. Cunt the number f different medicatins (nt the number f dses r different dsages) administered by any rute (e.g., ral, IV, injectins, patch) at any time during the last seven days. Include any rutine, prn, and stat dses given. Medicatins include tpical preparatins, intments, creams used in wund care (e.g., Elase), eyedrps, vitamins, and suppsitries. Tpical preparatins that are used fr preventative skin care (i.e. misturizers and misture barriers) shuld nt be cded here. Include any medicatin that the resident administers t self, if knwn. If the resident takes bth the generic and brand name f a single drug, cunt as nly ne medicatin. Antigens and vaccines als are cunted here. Write the apprpriate number in the answer bx. Cunt nly thse medicatins actually administered and received by the resident ver the last seven days. D nt cunt medicatins rdered but nt given.

Clarificatins: If a dietary supplement, given t a resident between meals, has a vitamin as ne f its ingredients, cde it as a dietary supplement, nt as a medicatin. Cding Examples: If a resident receives a daily Vitamin C capsule, add it t the medicatin cunt in number f medicatins (O1). If a resident receives a dietary supplement between meals and the label cntents specify that Vitamin C (r any ther vitamin, etc) is ne f the ingredients, cde (K5f = check) fr dietary supplement between meals. The basic TPN slutin itself (that is, the prtein/carbhydrate mixture r a fat emulsin) is nt cunted as a medicatin. The use f TPN is cded in Sectin K., Oral Nutritinal Status. Medicatins, such as electrlytes, vitamins, r insulin, which have been added t the TPN slutin, are cnsidered medicatins and shuld be cded in this sectin. Herbal and alternative medicine prducts are cnsidered t be dietary supplements by the Fd and Drug Administratin (FDA). They are nt regulated by the FDA (e.g., they are nt reviewed fr safety and effectiveness like medicatins) and their cmpsitin is nt standardized (e.g., the cmpsitin varies amng manufacturers). Therefre, they shuld nt be cunted in this item. These substances may be cded at MDS Item K5f, prvided they meet the definitin f dietary supplement fr this Item. Keep in mind that, fr clinical purpses, it is imprtant t dcument a resident s intake f such substances elsewhere in the clinical recrd and t mnitr their ptential effects, as they can interact with ther medicatins. Mre infrmatin n dietary supplements identified by the FDA can be fund at the fllwing web site: http://www.nih.gv/health. All medicatins used by the resident in the 7-Day assessment perid need t be cunted in Sectin O. All medicatins administered ff-site (e.g., while receiving dialysis r chemtherapy) must be cnsidered when cmpleting this item. The facility is respnsible fr cmmunicating with the utpatient site t identify the use f any medicatins received while the resident was under their care, and fr mnitring the effect, including any adverse effects, f medicatins after the resident s return t the facility. Cmbinatin prducts such as Crzide (which cntains a diuretic and a betablcker) are cunted as ne medicatin. Administratin f Epgen shuld be recrded in several places in Sectin O, depending n its rute f administratin and date f initiatin. It shuld be cunted at MDS Item O1 (Number f Medicatins), and if it was initiated during the last 90 days, it shuld als be indicated at MDS Item O2 (New

Medicatin). If the Epgen was given subcutaneusly, als recrd it in Item O3 (Injectins). If it is given intravenusly, it shuld be indicated at MDS Item P1ac (IV medicatin). Heparin included in a saline slutin used t irrigate a heparin lck is nt cunted in this item. Each type f insulin that a resident receives shuld be cunted separately. Fr example, Lente, Neutral Prtamine Hagedrn (NPH), and Regular are different types f insulin and are cnsidered different medicatins. Ensure r any nutritinal supplement is nt cunted as a medicatin fr cding in Sectin O. The dietary supplement culd be recrded in Sectin K5f, prvided it fits the definitins. If the resident received an injectin f Vitamin B12 prir t the bservatin perid, cde in Item O1. Vitamin B12 maintains a bld level, as d lng acting antipsychtics. Determine if a specific lng-acting medicatin is still active based n physician, pharmacist, and/r PDR input. D nt cde Vitamin B12 injectins in Item O3 (Injectins) if it was given utside f the bservatin perid. Recrd suppsitries in Item O1, Number f Medicatins. Fr facilities in states using Sectin U, als recrd in Sectin U. Example Resident was given Digxin 0.25 mg p n Tuesday and Thursday and Digxin 0.125 mg p n Mnday, Wednesday, and Friday. Althugh the dsage is different fr different days f the week, the medicatin is the same. Cde 1 (ne medicatin received).

O1. Number f Medicatins Cding This item is lking fr the number f different medicatins the resident actually received during the seven-day lk back perid. Tips The manual instructins fr this item are very detailed. As the manual indicates, d nt cunt the fllwing: The number f dses given f the same medicatin Different dsages f the same medicatin The same medicatin by a different name Medicatins rdered but nt administered Tpical preparatins used fr preventative skin care, such as misturizers and misture barriers TPN slutin Heparin included in saline slutin t irrigate a heparin lck Nutritinal supplements that cntain a vitamin r vitamins as sme f the ingredients (cde this in K5f) Herbal and alternative medicine prducts On the ther hand, d cunt the fllwing: Over-the-cunter as well as prescriptin drugs Medicatins administered by any rute Rutine dses administered Stat dses PRN dses Medicatins administered ff-site while a resident f the facility Self-administered medicatins Tpical preparatins, intments, and creams used in wund care, such as Elase Eye drps Vitamins Suppsitries Antigens, such as PPD Vaccines Medicatins added t TPN, such as electrlytes, vitamins, and insulin Other rules: Each type f insulin administered cunts as a separate medicatin. Cmbinatin prducts cunt as ne medicatin. Lng-acting medicatins, such as B12 and lng-acting antipsychtics, administered prir t the bservatin perid shuld be cunted if they are still active during the bservatin perid. T determine whether they are still active, cnsult a physician, pharmacist, r PDR fr input.